G
Gabriel Contreras
Researcher at University of Miami
Publications - 111
Citations - 9280
Gabriel Contreras is an academic researcher from University of Miami. The author has contributed to research in topics: Kidney disease & Lupus nephritis. The author has an hindex of 40, co-authored 103 publications receiving 8058 citations. Previous affiliations of Gabriel Contreras include Jackson Memorial Hospital.
Papers
More filters
Journal ArticleDOI
Intensity of renal support in critically ill patients with acute kidney injury
Paul M. Palevsky,Jane Hongyuan Zhang,Theresa Z. O'Connor,Glenn M. Chertow,Susan T. Crowley,Devasmita Choudhury,Kevin W. Finkel,John A. Kellum,Emil P. Paganini,Roland M. H. Schein,Mark W. Smith,Kathleen M. Swanson,B. Taylor Thompson,Anitha Vijayan,Suzanne Watnick,Robert A. Star,Peter Peduzzi,E. Young,R. Fissel,W. Fissel,Uptal D. Patel,K. Belanger,A. Raine,N. Ricci,James B. Lohr,P. Arora,D. Cloen,D. Wassel,L. Yohe,J. Amanzadeh,J. Penfield,M. Hussain,R. Katneni,A. Sajgure,A. Swann,G. Dolson,V. Ramanathan,G. Tasby,Robert L. Bacallao,M. Jaradat,Kenneth Edward Graves,Q. Li,M. Krause,M. Shaver,M. Alam,K. Morris,T. Bland,E. Satter,Jeffrey A. Kraut,A. Felsenfeld,B. Levine,G. Nagami,B. Vaghaiwalla,J. Duffney,Joseph O. Moore,C. Cely,E. Jaimes,Daniel H. Kett,Andrew A. Quartin,M. Arcia,A. Barchi-Chung,Vecihi Batuman,A. Alper,A. Dreisbach,E. Simon,C. Kulivan,Nabeel Aslam,M.C. Ramkumar,E. Grum,P. Rogers,Steven D. Weisbord,C. Geffel,Ihab M. Wahba,Darren J. Kelly,J. Walczyk,George Feldman,A. Mogyorosi,G. Viol,M. Halverson,S. Schmid,H. Totten,Francis B. Gabbai,S. Mullaney,R. Smith,J. Dingsdale,S. Woods,Kirsten L. Johansen,David H. Lovett,Ann M. O’Hare,James T. McCarthy,C. Rosado-Rodriguez,A. Galera,G. Rodriguez-Vega,W. Rodriguez,C. Vilchez,B. Young,Dennis L. Andress,A. Lindner,G. Galvin,N. Gourley,Aldo J. Peixoto,M. Perkal,C. Joncas,Sevag Demirjian,J. Yared,R. Brienza,M. Garcia,T. Seifert,L. Sweeney,Hamid Rabb,Mohamed G. Atta,Roy G. Brower,M. Choi,Joseph A. Eustace,Paul J. Scheel,E. Heck,H. Rahman,John L. Niles,H. Bazari,K. Smirnakis,D. Steele,Ravi Thadhani,K. Laliberte,B. Leeman,C. McCarthy,M. Pescatore,Harold M. Szerlip,P. Fall,M. Jagadeesan,Laura L Mulloy,William D Paulson,J. White,N. Sickafoose,K. Cho,M. Gropper,K. Liu,Michael A. Matthay,K. Borovitz,M. Koenigsberg,S. Rodriguez,Gabriel Contreras,S. Cohn,J. Diego,C. Carvalho,D. Carvalho,M. Castro,C. de la Cuesta,I. Espinal,A. Hurtado,P. Oyuela,Mark Unruh,Renee Burr,Michael P. Donahoe,J. Marszalek,M. Shields,R. Venkataraman,J. Aubrecht,H. Sterling,L. Mandich,A. Shaw,J. Foringer,J. Samuels,B. Efron,Michael V. Rocco,E. Deterding,Shahriar Moossavi,C. Bethea,D. McBride,Stuart R. Warren,M. Kollef,K. Sambandam,E. Hammer,M. Hoffman,John B. Stokes,Alfred F. Connors,Harold I. Feldman,Joel W. Greer,G. G. Koch,Thomas E. Stewart,Janet Wittes,P. Overberger,S. Michler,Massimo Antonelli,K. Dellert,L. Durant,R. Franchini,A. Kossack,V. McBride,S. O'Neil,Taposh Roy,J. Russo,Joseph N. Vitale,Mike R. Sather,C. Fye,C. M. Haakenson,D. H. Krueger,J. Thornton,C. Dalzell,R. Horney,Andrew M. Siroka,P. Su,Mary Brophy,D. Humphries,D. Govan,Timothy J. O'Leary,G. D. Huang,John R. Feussner,Paul W. Eggers +207 more
TL;DR: Intensive renal support in critically ill patients with acute kidney injury did not decrease mortality, improve recovery of kidney function, or reduce the rate of nonrenal organ failure as compared with less-intensive therapy.
Journal ArticleDOI
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Gerald B. Appel,Gabriel Contreras,Mary Anne Dooley,Ellen M. Ginzler,David A. Isenberg,David Jayne,Lei Shi Li,Eduardo Mysler,Jorge Sánchez-Guerrero,Neil Solomons,David Wofsy,Carlos Abud,Sharon G. Adler,Graciela S. Alarcón,Elisa N. Albuquerque,Fernando Almeida,Alejandro Alvarellos,Gerald B. Appel,Hilario Avila,Cornelia Blume,Ioannis Boletis,Alain Bonnardeaux,Alan Braun,Jill P. Buyon,Ricard Cervera,Nan Chen,Shun-Le Chen,António Gomes Da Costa,Razeen Davids,David D'Cruz,Enrique de Ramón,Atul Deodhar,Andrea Doria,Bertrand Dussol,Paul Emery,Justus Fiechtner,Jürgen Floege,Hilda Fragoso-Loyo,Richard Furie,Rozina Ghazalli,Cybele Ghossein,Gary S. Gilkeson,EM Ginzler,Caroline Gordon,Jennifer M. Grossman,Jieruo Gu,Loïc Guillevin,Pierre Yves Hatron,Gisela Herrera,Falk Hiepe,Frédéric Houssiau,Osvaldo Hübscher,Claudia Hura,Joshua Kaplan,Gianna Mastroianni Kirsztajn,Emese Kiss,Ghazali Ahmad Kutty,Maurice Laville,Maria Lazaro,Oliver Lenz,Leishi Li,Liz Lightstone,Sam Lim,Michel Malaise,Susan Manzi,Juan Carlos Marcos,Olivier Meyer,Pablo Monge,Saraladev Naicker,Nathaniel Neal,Michael Neuwelt,Kathy Nicholls,Nancy J. Olsen,José Ordi-Ros,Barbara E. Ostrov,Manuel Pestana,Michelle Petri,G. Pokorny,Jacques Pourrat,Jiaqi Qian,Jai Radhakrishnan,Brad H. Rovin,Julio Sanchez Roman,Joseph C. Shanahan,William Shergy,Fotini Skopouli,Alberto Spindler,Christopher Striebich,Robert Sundel,Charles R. Swanepoel,Yen Tan Si,Guillermo Tate,Vladimír Tesaŕ,Mohamed Tikly,Haiyan Wang,Rosnawati Yahya,Xueqing Yu,Fengchun Zhang,Diana Zoruba +98 more
TL;DR: Although most patients in both treatment groups experienced clinical improvement, the study did not meet its primary objective of showing that MMF was superior to IVC as induction treatment for lupus nephritis.
Journal ArticleDOI
Sequential therapies for proliferative lupus nephritis
Gabriel Contreras,Victoriano Pardo,Baudouin Leclercq,Oliver Lenz,E. Tozman,Patricia O'Nan,David M. Roth +6 more
TL;DR: For patients with proliferative lupus nephritis, short-term therapy with intravenous cyclophosphamide followed by maintenance therapy with mycophenolate mofetil or azathioprine appears to be more efficacious and safer than long-term Therapy with intravenously cycloph phosphamide.
Journal ArticleDOI
Intensive blood-pressure control in hypertensive chronic kidney disease.
Lawrence J. Appel,Jackson T. Wright,Tom Greene,Lawrence Y. Agodoa,Brad C. Astor,George L. Bakris,William H. Cleveland,Jeanne Charleston,Gabriel Contreras,Marquetta Faulkner,Francis B. Gabbai,Jennifer J. Gassman,Lee A. Hebert,Kenneth Jamerson,Joel D. Kopple,John W. Kusek,James P. Lash,Janice P. Lea,Julia B. Lewis,Michael S. Lipkowitz,Shaul G. Massry,Edgar R. Miller,Keith C. Norris,Robert A. Phillips,Velvie A. Pogue,Otelio S. Randall,Stephen G. Rostand,Miroslaw Smogorzewski,Robert D. Toto,Xuelei Wang +29 more
TL;DR: Overall analyses, intensive blood-pressure control had no effect on kidney disease progression, however, there may be differential effects of intensiveBlood pressure control in patients with and those without baseline proteinuria, as well as according to the baseline level of proteinuria.
Journal ArticleDOI
Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis
Mary Anne Dooley,David Jayne,Ellen M. Ginzler,David A. Isenberg,Nancy J. Olsen,David Wofsy,Frank Eitner,Gerald B. Appel,Gabriel Contreras,Laura Lisk,Neil Solomons +10 more
TL;DR: Mycophenolate mofetil was superior to azathioprine in maintaining a renal response to treatment and in preventing relapse in patients with lupus nephritis who had a response to induction therapy.